Pre-clinical Support

We support regulatory approvals, mitigates risks, accelerates development timelines, and builds confidence among authorities, investors, and stakeholders.

pre-clinical Support at CurexBio

The CurexBio Advantage: Strategic Pre-Clinical Support

Choosing CurexBio for your pre-clinical services means partnering with a CRO that truly understands the intricate demands of early-stage drug development. We offer:

  • Integrated Expertise: Seamless coordination between strategy, execution, and subsequent clinical development planning.
  • Regulatory Acumen: Deep understanding of global regulatory requirements aligned with OECD Principles of Good Laboratory Practice (GLP) and FDA 21 CFR Part 58 Regulations to ensure your preclinical data is compliant and acceptable for drug approvals.
  • Risk Reduction: Proactive identification and mitigation of potential challenges, saving time and resources in the long run.
  • Efficiency and Agility: Streamlined processes and flexible approaches to adapt to your project’s unique needs.
  • Data Quality: Unwavering commitment to GLP compliance and scientific rigor, ensuring the reliability of your pharmacokinetic drug profile and other key data points.

Let CurexBio be your strategic partner in building a strong, scientifically sound foundation for your therapeutic innovations, accelerating their journey towards successful drug approvals and ultimately, improving patient lives.

Types of Studies Supported:

Why Choose Curexbio for Pre-clinical Support?

quality

Science Team

Scientifically driven team with deep subject matter expertise
curexbio

Pre-Clinical Experts

Extensive experience in a broad range of pre-clinical studies
curexbio

Data to Clinic Flow

Commitment to data quality, regulatory alignment, and successful clinical transition
curexbio

Tailored R&D Plans

Personalized strategies tailored to your molecule, indication, and development goals.

Request For Proposal

We offer an array of niche and full-fledged CRO services, from clinical trial protocol development to post-marketing surveillance. Streamline Your Drug Development with Curexbio CRO Expertise

What People Ask...

CurexBio offers strategic pre-clinical support with integrated expertise, regulatory knowledge, and a scientifically driven team. We follow global standards such as GLP and FDA regulations, ensuring high-quality, compliant data that supports successful regulatory approvals and smooth transition to clinical trials.

CurexBio accelerates drug development by combining risk mitigation strategies, streamlined processes, and tailored R&D plans. Our team ensures efficient study execution, reliable data generation, and alignment with regulatory requirements to reduce delays and improve overall development timelines.

Pre-clinical support involves laboratory and animal studies that evaluate the safety, toxicity, pharmacokinetics (PK), and pharmacodynamics (PD) of a drug before human trials. These studies are essential for determining whether a drug candidate is safe and effective enough to move into clinical phases.

Pre-clinical research includes toxicology studies (acute and repeat-dose), genetic and eco-toxicology, DMPK studies, dose range finding, and IND/NDA-enabling studies. These studies help identify potential risks and establish safe dosage levels before clinical trials begin.

GLP (Good Laboratory Practice) compliance ensures that pre-clinical studies are conducted with high standards of quality, consistency, and reliability. It helps generate accurate and reproducible data that regulatory authorities can trust for drug approval decisions.

Curexbio Insights Hub

Dive into the latest research, insights, and innovations with our team of experts in the fields that matter most to clinical advancement.
Curexbio Insights Hub